Regularly consuming aspirin could potentially decrease the likelihood of a subsequent heart attack or stroke
In a comprehensive study involving over 40,000 individuals aged 40 and above who suffered their first heart attack between 2004 and 2017, the benefits of daily low-dose aspirin for secondary prevention have been highlighted [1].
The antiplatelet effect of aspirin is particularly beneficial in patients with a history of cardiovascular events. By inhibiting platelet aggregation, aspirin helps prevent further blood clots that can block arteries supplying the heart or brain, thereby lowering the incidence of subsequent heart attacks and strokes [2][3].
The study found that people who took aspirin as prescribed were less likely to experience another heart attack, stroke, or death than non-adherence for all four-time points [1]. In high-income countries, 65% of people with previous cardiovascular events take aspirin, while the rate drops to about 16% in low-income countries [1].
However, it's important to note that aspirin carries risks, primarily related to increased bleeding. These risks include gastrointestinal bleeding, hemorrhagic stroke (bleeding in the brain), and potential blood pressure effects [1]. Aspirin does not reliably lower blood pressure in most patients and may increase blood pressure in those with hypertension [1].
Despite these risks, the benefits in secondary prevention are generally greater than the bleeding risk. As a result, aspirin is commonly recommended in patients who have experienced a cardiovascular event. However, the decision to use aspirin daily should be individualized and made in consultation with a healthcare provider who can evaluate the patient’s bleeding risk and overall cardiovascular profile [1][4].
Factors influencing a doctor's recommendations on aspirin include potential drug interactions, such as with Eliquis [1]. It's essential for individuals not to make medical decisions independently, but to consult with their doctors.
The study, presented at the ESC Congress 2023, examines the risk associated with discontinuing long-term aspirin use compared to continued use after a heart attack [1]. Aspirin compliance declined at each checkpoint: 90% at two years, 84% at four years, 82% at six years, and 81% at eight years [1].
At the two-year follow-up, those who had stopped taking aspirin had a 29% higher likelihood of a recurrent event. At the four-year follow-up, the participants no longer taking aspirin were 40% more likely to have a second event. This trend continued, with a 31% higher likelihood at the six-year follow-up and a 20% higher likelihood at the eight-year follow-up [1].
In conclusion, daily low-dose aspirin is effective and recommended for reducing recurrent heart attacks and strokes in patients with prior cardiovascular events. However, the bleeding risk requires careful consideration and monitoring [2][3][4]. As always, it's essential to consult with a healthcare provider before making any decisions regarding medication.
Dr. Yu-Ming Ni supports the study's findings, emphasizing the significance of aspirin for secondary prevention of heart events [1]. Reasons for underutilization of aspirin may include varying accessibility to healthcare, inconsistent messaging, and aspirin not being available over the counter in some countries [1].
In light of these findings, it's crucial to ensure that individuals at risk of recurrent heart attacks and strokes have access to the necessary medication and information to make informed decisions about their health.
- The benefits of daily low-dose aspirin for secondary prevention, particularly in patients with a history of cardiovascular events, are significant in lowering the incidence of subsequent heart attacks and strokes.
- Science and medical research emphasize the importance of aspirin for the prevention of recurrent heart attacks and strokes, although its antiplatelet effect comes with potential risks, such as increased bleeding.
- Informing individuals with prior cardiovascular conditions about their health and wellness, including the cardiovascular health implications and risks associated with aspirin and other pain medications, is crucial to make informed decisions about their treatment plans.
